Suppr超能文献

腰椎椎间孔硬膜外注射治疗慢性下腰痛和下肢疼痛:一项系统评价

Lumbar interlaminar epidural injections in managing chronic low back and lower extremity pain: a systematic review.

作者信息

Parr Allan T, Diwan Sudhir, Abdi Salahadin

机构信息

Premier Pain Center, Covington, LA 70433, USA.

出版信息

Pain Physician. 2009 Jan-Feb;12(1):163-88.

Abstract

BACKGROUND

Low back pain with or without lower extremity pain is the most common problem among chronic pain disorders with significant economic, societal, and health impact. Epidural injections are one of the most commonly performed interventions in the United States in managing chronic low back pain. However the evidence is highly variable among different techniques utilized - namely interlaminar, caudal, transforaminal - and for various conditions, namely - intervertebral disc herniation, spinal stenosis, and discogenic pain without disc herniation or radiculitis.

STUDY DESIGN

A systematic review of lumbar interlaminar epidural injections with or without steroids.

OBJECTIVE

To evaluate the effect of lumbar interlaminar epidural injections with or without steroids in managing various types of chronic low back and lower extremity pain emanating as a result of disc herniation or radiculitis, spinal stenosis, and chronic discogenic pain.

METHODS

Review of the literature and methodologic quality assessment were performed according to the Cochrane Musculoskeletal Review Group Criteria as utilized for interventional techniques for randomized trials and the Agency for Healthcare Research and Quality (AHRQ) criteria for observational studies. The level of evidence was classified as Level I, II, or III based on the quality of evidence developed by the U.S. Preventive Services Task Force (USPSTF) for therapeutic interventions. Data sources included relevant literature of the English language identified through searches of PubMed and EMBASE from 1966 to November 2008, and manual searches of bibliographies of known primary and review articles. Results of analysis were performed for multiple conditions separately.

OUTCOME MEASURES

The primary outcome measure was pain relief (short-term relief = up to 6 months and long-term > 6 months). Secondary outcome measures were improvement in functional status, psychological status, return to work, and reduction in opioid intake.

RESULTS

The available literature included only blind epidural injections without fluoroscopy. The indicated evidence is positive (Level II-2) for short-term relief of pain of disc herniation or radiculitis utilizing blind interlaminar epidural steroid injections with lacking of evidence with Level III for long-term relief for disc herniation and radiculitis. The evidence is lacking with Level III for short and long-term relief for spinal stenosis and discogenic pain without radiculitis or disc herniation utilizing blind epidural injections.

LIMITATIONS

The limitations of this study include paucity of literature, lack of quality evidence, lack of fluoroscopic procedures, and lack of applicable evidence in contemporary interventional pain management practices.

CONCLUSION

The evidence based on this systematic review is limited for blind interlaminar epidurals in managing all types of pain except for short-term relief of pain secondary to disc herniation and radiculitis. This evidence does not represent contemporary interventional pain management practices and also the evidence may not be extrapolated to fluoroscopically directed lumbar interlaminar epidural injections.

摘要

背景

伴有或不伴有下肢疼痛的腰痛是慢性疼痛疾病中最常见的问题,对经济、社会和健康都有重大影响。硬膜外注射是美国治疗慢性腰痛最常用的干预措施之一。然而,在不同的技术(即椎板间、骶管、经椎间孔)以及各种病症(即椎间盘突出症、椎管狭窄症以及无椎间盘突出或神经根炎的椎间盘源性疼痛)中,证据差异很大。

研究设计

对使用或不使用类固醇的腰椎椎板间硬膜外注射进行系统评价。

目的

评估使用或不使用类固醇的腰椎椎板间硬膜外注射在治疗因椎间盘突出症或神经根炎、椎管狭窄症以及慢性椎间盘源性疼痛引起的各种类型慢性腰痛和下肢疼痛方面的效果。

方法

根据用于随机试验干预技术的Cochrane肌肉骨骼评价组标准以及用于观察性研究的医疗保健研究与质量局(AHRQ)标准进行文献综述和方法学质量评估。根据美国预防服务工作组(USPSTF)制定的治疗干预证据质量,证据水平分为I级、II级或III级。数据来源包括通过检索1966年至2008年11月的PubMed和EMBASE数据库确定的英文相关文献,以及对已知主要文章和综述文章参考文献的手工检索。分别对多种病症进行分析结果。

观察指标

主要观察指标是疼痛缓解(短期缓解=长达6个月,长期缓解>6个月)。次要观察指标是功能状态、心理状态的改善、重返工作岗位以及阿片类药物摄入量的减少。

结果

现有文献仅包括无荧光透视的盲法硬膜外注射。对于使用盲法椎板间硬膜外类固醇注射短期缓解椎间盘突出症或神经根炎疼痛,所示证据为阳性(II-2级),而对于椎间盘突出症和神经根炎的长期缓解缺乏III级证据。对于使用盲法硬膜外注射治疗椎管狭窄症以及无神经根炎或椎间盘突出的椎间盘源性疼痛的短期和长期缓解,缺乏III级证据。

局限性

本研究的局限性包括文献匮乏、缺乏高质量证据、缺乏荧光透视程序以及当代介入性疼痛管理实践中缺乏适用证据。

结论

基于本系统评价的证据,对于盲法椎板间硬膜外注射治疗除椎间盘突出症和神经根炎继发的短期疼痛缓解之外的所有类型疼痛是有限的。该证据不代表当代介入性疼痛管理实践,并且该证据也不能外推至荧光透视引导下的腰椎椎板间硬膜外注射。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验